Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers
Clinical trial NCT03115996 · COMPLETED
Trial details
- NCT number
- NCT03115996
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2018-08-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.